Maintaining our place as a trusted health evidence producer: the Future of Evidence Synthesis programme
Ella Flemyng, Cochrane Central Executive Team
Frances Kellie, Cochrane
Gert Van Valkenhoef, Cochrane
Rachel Craven, Cochrane
Rachel Klabunde, Cochrane Central Executive Team
Ruth Foxlee, Cochrane
Toby Lasserson, Cochrane Central Executive Team
Ursula Gonthier, Cochrane Central Executive Team
The global health, research and publishing landscape has changed beyond recognition since our organization began in the early 1990s – giving rise to both complex challenges and new opportunities for Cochrane. To maintain our hard-earned place as one of the world’s most trusted health evidence producers, we need to adapt and directly address a diverse range of critical issues – from the loss of traditional funding sources and the move to a fully Open Access model, to the increasing demand for rapid evidence in new formats.
To ensure Cochrane’s future we are working to deliver a new model for producing Cochrane evidence syntheses through our Future of Evidence Synthesis programme. This transformational programme of work will roll out over the next three to four years and is made up of ten targeted projects, encompassing changes to our organizational structure, software, review development and editorial processes, policies and the format of Cochrane Reviews.
This Special Session is an opportunity for people to understand better how key projects will impact on the Cochrane evidence synthesis ecosystem and what these changes will mean for people across the Cochrane Community. There will be an opportunity to ask questions about the programme and provide ideas that will contribute towards successful implementation.
Target audience: Anyone interested in how Cochrane produces high-quality evidence synthesis in the future.
Format: Presentations plus discussion / Questions & Answers